Product Information

QUETIAPINE FUMARATE 300 MG TAB is a generic product labeled by American Health Packaging, priced at $0.1352 per EA under NDC 60687037101. Its NADAC has been published 432 times since Aug 15, 2018.

FDA first approved this application on Mar 27, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

QUETIAPINE FUMARATE 300 MG TAB

Quetiapine
$0.1352per EA

Strength

300 mg/1

NDC

60687037101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

QUETIAPINE FUMARATE

Approval Type

Generic (ANDA)

FDA Application

ANDA201109

FDA Approved

3/27/2012

TE Code

AB

On Market Since

6/27/2018

Pharmacological Classes

Price Statistics

The NADAC for QUETIAPINE FUMARATE 300 MG TAB has been published 432 times since Aug 15, 2018, and over the history we have for it it has declined 34.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1352 per EA
All-time high$0.2063 (Aug 15, 2018)
All-time low$0.1136 (Nov 20, 2024)
52-week high$0.1465
52-week low$0.1265
Median price$0.1520
Average price$0.1574
Largest weekly change-26.7% (Nov 20, 2024)
Weeks tracked432
Tracking sinceAug 15, 2018

Price History

1W

+5.8%

1M

+6.1%

3M

+5.2%

6M

-7.7%

1Y

+2.9%

3Y

-8.4%

5Y

-5.1%

All

-34.5%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of QUETIAPINE FUMARATE 300 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE FUMARATE 300 MG TAB, manufactured by American Health Packaging, is $0.1352 per EA (NDC 60687037101), effective Nov 18, 2026.

How has the price of QUETIAPINE FUMARATE 300 MG TAB changed over time?

Over the history we have for it, the NADAC for QUETIAPINE FUMARATE 300 MG TAB has declined 34.5%. It has been tracked across 432 weekly CMS publications since Aug 15, 2018.

What are the highest and lowest recorded NADAC prices for QUETIAPINE FUMARATE 300 MG TAB?

Since Aug 15, 2018, the NADAC for QUETIAPINE FUMARATE 300 MG TAB has ranged from a low of $0.1136 (Nov 20, 2024) to a high of $0.2063 (Aug 15, 2018), with a median of $0.1520 per EA.

Are there cheaper alternatives to QUETIAPINE FUMARATE 300 MG TAB?

Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUETIAPINE FUMARATE 300 MG TAB, is $0.1330 per EA — about 2% below QUETIAPINE FUMARATE 300 MG TAB.

Who manufactures QUETIAPINE FUMARATE 300 MG TAB?

QUETIAPINE FUMARATE 300 MG TAB (NDC 60687037101) is labeled by American Health Packaging, and CMS classifies it as a generic product.